We are live on ! Find out more
SSKN

Strata Skin Sciences

Delisted

SSKN was delisted on the 18th of February, 2026.

25 hedge funds and large institutions have $15.8M invested in Strata Skin Sciences in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

4% more funds holding

Funds holding: 24 → 25 (+1)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

3.69% less ownership

Funds ownership: 26.57% → 22.88% (-3.7%)

16% less capital invested

Capital invested by funds: $18.8M → $15.8M (-$2.98M)

Holders
25
Holders Change
+1
Holders Change %
+4.17%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SSKN Hedge Fund Activity: Q4 2019 in Review

25 of the 5,093 institutional investors tracked by Wall St. Rank reported a position in Strata Skin Sciences (SSKN) for Q4 2019, worth a combined $15.8M — down 16% from $18.8M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new SSKN positions and 3 closed out — a net gain of 1 holder — while 6 added to existing stakes and 6 trimmed.

The largest buyer was Cannell Capital, adding an estimated $359K. The largest seller was Broadfin Capital, cutting an estimated $2.45M.

  • 25 institutional investors held Strata Skin Sciences (SSKN) as of Q4 2019, up from 24 in Q3 2019.
  • Funds reported $15.8M of Strata Skin Sciences stock for Q4 2019, down 16% quarter-over-quarter.
  • 4 funds opened new Strata Skin Sciences positions in Q4 2019 and 3 closed out, a net change of +1 holder.
  • The largest Strata Skin Sciences buyer in Q4 2019 was Cannell Capital, an estimated $359K added.
  • The largest Strata Skin Sciences seller in Q4 2019 was Broadfin Capital, an estimated $2.45M sold.

Based on aggregated 13F filings for Q4 2019.